NDC product
Cetacaine Topical Anesthetic
NDC 10223-0221 · Cetylite Industries, Inc.
Key facts
| Product NDC | 10223-0221 |
|---|---|
| Proprietary name | Cetacaine Topical Anesthetic |
| Nonproprietary name | Benzocaine, Butamben, and Tetracaine Hydrochloride |
| Substances | BENZOCAINE, BUTAMBEN, TETRACAINE HYDROCHLORIDE |
| Dosage form | GEL |
| Route | TOPICAL |
| Labeler | Cetylite Industries, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Ester Local Anesthetic [EPC], Esters [CS], Increased Histamine Release [PE], Local Anesthesia [PE] and 1 more |
| Marketing start | Jan 1, 1960 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: